CLK1 inhibition may prevent chemoresistance in glioma, and CLK1 inhibition by TG693 allows the skipping of mutated exon 31 of the dystrophin gene in Duchenne Muscular Dystrophy. This evidence concerns the gene CLK1 and central nervous system cancer.